CTAS monthly performance report
Explore CTAS's monthly returns, drawdown, and seasonality trends — updated every month.
CTAS monthly report
—
Key takeaways
- Cintas (CTAS) closed November 2026 at $226.24, up 2.92% for the month and +20.40% over the trailing 12 months.
- Year-to-date, CTAS is +20.30%, outperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading +17.85% versus its 200-day moving average ($191.97), a bullish technical signal.
- Over the past three years, CTAS has underperformed the S&P 500 by −2.63%, with a relative strength index reading of 98.5.
- Win rate over the trailing 39 months stands at 61.5% — 24 positive months versus 15 negative months.
Cintas ended November 2026 at $226.24, posting a monthly return of +2.92%. The S&P 500 returned −0.18% over the same window, leaving relative performance at +3.10%.
The current quarter stands at +15.98% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +17.85% versus the 200-day moving average ($191.97).
Year-to-date, CTAS is +20.30% against SPY +10.62%, a gap of +9.67%. The stock is currently −3.08% below its 52-week high, with maximum 3-year drawdown at −28.16%.
| Period | CTAS | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.56% | −0.36% | −0.20% |
| 1 Week | +1.74% | +2.59% | −0.85% |
| 1 Month | +2.92% | −0.18% | +3.10% |
| 3 Months | +14.37% | −2.37% | +16.74% |
| 6 Months | +36.33% | +0.83% | +35.50% |
| YTD | +20.30% | +10.62% | +9.67% |
| 12 Months | +20.40% | +12.25% | +8.15% |
| 3 Years | +68.75% | +71.37% | −2.63% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2026 | +20.31% |
| #2 | Oct 2026 | +12.69% |
| #3 | Jan 2025 | +9.78% |
| #4 | Nov 2024 | +9.71% |
| #5 | Mar 2024 | +9.30% |
| Rank | Month | Return |
|---|---|---|
| #1 | Dec 2024 | −19.08% |
| #2 | Mar 2026 | −15.91% |
| #3 | Oct 2025 | −10.71% |
| #4 | Aug 2025 | −5.63% |
| #5 | Sep 2023 | −4.59% |
| Quarter | Return |
|---|---|
| Q3 2025 | −7.90% |
| Q4 2025 | −8.37% |
| Q1 2026 | −10.07% |
| Q2 2026 | +0.56% |
| Q3 2026 | +14.69% |
| Q4 2026 (QTD) | +15.98% |
| Year | Return |
|---|---|
| 2023 | +33.45% |
| 2024 | +21.27% |
| 2025 | +2.94% |
| 2026 | +20.30% |
| Metric | Value |
|---|---|
| 52-Week High | $233.42 (2026-11-05) |
| 52-Week Low | $161.16 (2026-05-13) |
| Current Price | $226.24 |
| 200-Day Moving Average | $191.97 |
| Price vs 200DMA | +17.85% |
| 3-Year Maximum Drawdown | −28.16% (2026-05-13) |
| Current Drawdown from 52W High | −3.08% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 98.5 |
| 3-Year Excess Return vs S&P 500 | −2.63% |
| RS Peak | 128.3 (Apr 2025) |
| RS Trough | 72.3 (May 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was CTAS's return for this report period?
CTAS returned +2.92% in the latest monthly window ending 2026-11-13.
Has CTAS outperformed SPY year to date?
YTD CTAS: +20.30% vs SPY: +10.62%.
What is CTAS's 12-month return?
+20.40% over the trailing 12 months.
Is CTAS above or below its 200-day moving average?
Price is +17.85% versus 200DMA ($191.97).
What is the maximum drawdown in the 3-year window?
−28.16% on 2026-05-13.